NCT07070362 Digital Early Warning System for Acute Lung Injury in Liver Surgery
| NCT ID | NCT07070362 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tsinghua Chang Gung Hospital |
| Condition | Acute Lung Injury(ALI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2024-11-01 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on developing an explainable machine learning model based on cardiopulmonary interaction characteristics to achieve early prediction of acute lung injury (ALI) in patients undergoing major liver surgery. The research will establish a digital early-warning system for ALI to provide support for clinical diagnosis and treatment decisions, thereby reducing the incidence and fatality rate of ALI.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Undergoing major liver surgery (including two-segment or more hepatectomy, liver transplantation, etc.) * Voluntary participation with signed informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07070362 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Lung Injury(ALI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07070362 currently recruiting?
Yes, NCT07070362 is actively recruiting participants. Contact the research team at btchgzf@hotmail.com for enrollment information.
Where is the NCT07070362 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07070362 clinical trial?
NCT07070362 is sponsored by Beijing Tsinghua Chang Gung Hospital. The trial plans to enroll 4,000 participants.